Jingyuan Luo, an intern for the Baker Institute Science and Technology Policy Program and a senior at Rice University, blogs about the recent case overturning the notion that genes can be patented. If the case, ACLU vs. Myraid Genetics, is upheld at the appellate level, the biotechnical industry could face serious repercussions, writes Luo, who was recently awarded the prestigious Marshall Scholarship:
"It is likely that companies like Myriad would have less incentive to invest billions of research dollars in developing future diagnostic tests. ... How do you incentivize intellectual creativity while also disseminating the results of that creativity?"
Kirstin R.W. Matthews , Ana S. Iltis , Daniel S. Wagner
Feb 26 2021 | Center for Health and Biosciences
Feb 26 2021 | Center for Energy Studies